We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults with a loss-of-function mutation in the MC4R gene ...
Food intake and energy expenditure were thought to be simultaneously controlled by the same group of neurons, but now new evidence shows that they are independently regulated by an anatomically ...
Palatin (PTN) Technologies announced that preclinical data from the Company’s melanocortin 4 receptor, or MC4R, selective PL7737 obesity program will be highlighted in a poster presentation at ...
Primary endpoint met in the 8-week treatment study (highly statistically significant). Co-administered group had a 4.4% reduction in weight compared to 1.6% for the placebo group (p<0.0001). Primary ...
Please provide your email address to receive an email when new articles are posted on . Adults with severe obesity due to a melanocortin‐4 receptor deficiency have a longer gastric emptying time and ...
-- Bivamelagon achieved BMI reductions in patients with acquired hypothalamic obesity of -9.3% and -7.7% in 600mg and 400mg cohorts, respectively, at 14 weeks -- -- Post-hoc analysis showed BMI ...
Background: Melanocortin-4 receptor (MC4R) mutations have been reported as the most common single genetic cause of obesity in some populations and it has been suggested that they may be responsible ...
An impressive large-scale genetic study, led by scientists at the University of Cambridge, has homed in on a number of specific variants in a single gene that can help people either lose or gain ...
CRANBURY, N.J., March 31, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results